2020 Program Panel Topics Preview
- Prioritizing Real-World Evidence for Regulatory Discussions
- New Treatment Approaches for Solid Tumors
- Cross-Border Deal Making Challenges and Opportunities
- Innovations in Cardiovascular Drugs
- New Modalities: Critical Success Factors for Gene and Cell Therapies
- Expanding Neuroscience Pipeline Target Lists
- Regulatory Outlook: Lessons for Globalizing Clinical Trials